C反応性タンパク質検査市場 - 世界の産業規模、シェア、動向、機会、予測、アッセイタイプ別、検出範囲別、疾患領域別、最終用途産業別、地域別、競合別、2020年～2030年

世界のC反応性タンパク質（CRP）市場は、2024年には16億8,020万米ドルとなり、2030年までのCAGRは2.10％と予測され、着実な成長が見込まれています。

CRP検査は広く利用されている検査室診断ツールで、血液中のC反応性タンパク質（炎症を示す肝臓産生バイオマーカー）の濃度を測定します。この検査は、感染症、傷害、慢性疾患に対する身体の炎症反応を評価するのに役立ちます。

ヘルスケア専門家は、感染症、自己免疫疾患、心血管疾患、手術後の合併症など、幅広い疾患の診断やモニタリングにCRP検査を頻繁に使用しています。検査結果は1リットル当たりミリグラム（mg/L）で報告され、炎症の重症度や進行度に関する貴重な知見を提供し、タイムリーな診断や疾病管理戦略をサポートします。

主要な市場促進要因

炎症性疾患と感染性疾患の有病率の増加

主要な市場課題

CRP値上昇における特異性の欠如

主要な市場動向

個別化医療の重視の高まり

目次

第1章 製品概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 C反応性タンパク質検査市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • アッセイタイプ別（免疫比濁法、ELISA、化学発光免疫測定法、その他）
  • 検出範囲別（hs-CRP、従来型CRP、cCRP）
  • 疾患領域別（心血管疾患、がん、関節リウマチ、炎症性腸疾患、子宮内膜症、狼瘡、その他）
  • 最終用途産業別（病院・診療所、研究所、介護付きヘルスケア施設、在宅ケア、その他）
  • 地域別
  • 企業別（2024年）
• 市場マップ

第6章 北米のC反応性タンパク質検査市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州のC反応性タンパク質検査市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋のC反応性タンパク質検査市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米のC反応性タンパク質検査市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのC反応性タンパク質検査市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第13章 世界のC反応性タンパク質検査市場：SWOT分析

第14章 競合情勢

• Thermo Fisher Scientific, Inc.
• F. Hoffmann-La Roche Ltd.
• Danaher Corp
• Quest Diagnostics
• Siemens Healthineers AG
• Abbott Laboratories Inc.
• Merck KGaAA
• Zoetis Inc.
• Ortho Clinical Diagnostics
• Getein Biotech, Inc.

第15章 戦略的提言

第16章 調査会社について・免責事項

Global C-reactive protein (CRP) testing market was valued at USD 1,680.20 million in 2024 and is expected to witness steady growth, with a projected compound annual growth rate (CAGR) of 2.10% through 2030. CRP testing is a widely utilized laboratory diagnostic tool that measures the concentration of C-reactive protein-a liver-produced biomarker indicative of inflammation-in the blood. This test is instrumental in evaluating the body's inflammatory response to infections, injuries, and chronic conditions.

Healthcare professionals frequently use CRP testing to diagnose and monitor a broad range of conditions, including infectious diseases, autoimmune disorders, cardiovascular ailments, and post-surgical complications. Test results, reported in milligrams per liter (mg/L), provide valuable insight into the severity and progression of inflammation, supporting timely diagnosis and disease management strategies.

Key Market Drivers

Increasing Prevalence of Inflammatory and Infectious Diseases

A primary factor fueling market expansion is the growing global burden of inflammatory and infectious diseases. CRP testing is a critical diagnostic and prognostic tool used to detect and monitor a wide spectrum of conditions, including infections, autoimmune diseases, and cardiovascular disorders. As the incidence of these conditions rises globally, the demand for reliable inflammatory biomarkers like CRP continues to grow.

CRP testing is particularly important in managing chronic inflammatory diseases such as rheumatoid arthritis (RA), inflammatory bowel disease (IBD), and lupus, as well as acute conditions like sepsis and pneumonia. It is estimated that 18 million individuals are affected by RA worldwide, with women comprising 70% of cases and over half of the affected population aged 55 or older. Notably, 13 million people suffer from moderate to severe RA, where early diagnosis and rehabilitation can significantly improve quality of life.

The rising prevalence of autoimmune and inflammatory conditions-driven by a combination of genetic, environmental, and lifestyle factors-has prompted broader adoption of CRP testing in routine clinical diagnostics.

Key Market Challenges

Lack of Specificity in Elevated CRP Levels

One of the key challenges limiting the market's full potential is the non-specific nature of elevated CRP levels. While CRP is a reliable marker of inflammation, it does not provide diagnostic specificity regarding the underlying cause. This ambiguity can complicate clinical decision-making, requiring additional tests to identify the root condition, thereby prolonging diagnosis and treatment initiation.

Furthermore, due to its generalized nature, CRP testing is sometimes ordered inappropriately or excessively, particularly in cases where inflammation may not be clinically significant. This can lead to unnecessary healthcare spending and inefficient utilization of resources, contributing to diagnostic overuse and potential overdiagnosis.

Key Market Trends

Growing Emphasis on Personalized Medicine

The increasing focus on personalized medicine represents a transformative trend shaping the CRP testing market. Personalized medicine seeks to tailor medical treatment based on individual patient profiles, including genetic characteristics, lifestyle, and biomarker data. CRP serves as a critical biomarker for inflammation, enabling healthcare providers to design more targeted and effective treatment plans.

CRP testing plays a pivotal role in risk assessment, particularly for cardiovascular diseases, where elevated CRP levels may signal higher risk and prompt preventive interventions tailored to an individual's needs. It also supports continuous disease monitoring, allowing clinicians to track inflammation over time and make informed adjustments to treatment regimens based on changing CRP values.

Key Market Players

• Thermo Fisher Scientific, Inc.
• F. Hoffmann-La Roche Ltd.
• Danaher Corp
• Quest Diagnostics
• Siemens Healthineers AG
• Abbott Laboratories Inc.
• Merck KGaAA
• Zoetis Inc.
• Ortho Clinical Diagnostics
• Getein Biotech, Inc.

Report Scope:

In this report, the Global C-reactive Protein Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

C-reactive Protein Testing Market, By Assay Type:

• Immunoturbidimetric Assay
• ELISA
• Chemiluminescence Immunoassay
• Others

C-reactive Protein Testing Market, By Detection Range:

• hs-CRP
• Conventional CRP
• cCRP

C-reactive Protein Testing Market, By Disease Area:

• Cardiovascular Diseases
• Cancer
• Rheumatoid Arthritis
• Inflammatory Bowel Disease
• Endometriosis
• Lupus
• Others

C-reactive Protein Testing Market, By End-User:

• Hospitals & Clinics
• Laboratories
• Assisted Living Healthcare Facilities
• Homecare
• Others

C-reactive Protein Testing Market, By region:

• North America
  • United States
  • Canada
  • Mexico
• Asia-Pacific
  • China
  • India
  • South Korea
  • Australia
  • Japan
• Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global C-reactive Protein Testing Market.

Available Customizations:

Global C-reactive Protein Testing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. C-reactive Protein Testing Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Assay Type (Immunoturbidimetric Assay, ELISA, Chemiluminescence Immunoassay, Others)
  • 5.2.2. By Detection Range (hs-CRP, Conventional CRP, cCRP)
  • 5.2.3. By Disease Area (Cardiovascular Diseases, Cancer, Rheumatoid Arthritis, Inflammatory Bowel Disease, Endometriosis, Lupus, Others)
  • 5.2.4. By End-Use Industry (Hospitals & Clinics, Laboratories, Assisted Living Healthcare Facilities, Homecare, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America C-reactive Protein Testing Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Assay Type
  • 6.2.2. By Detection Range
  • 6.2.3. By Disease Are
  • 6.2.4. By End-Use Industry
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States C-reactive Protein Testing Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Assay Type
      • 6.3.1.2.2. By Detection Range
      • 6.3.1.2.3. By Disease Are
      • 6.3.1.2.4. By End-Use Industry
  • 6.3.2. Canada C-reactive Protein Testing Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Assay Type
      • 6.3.2.2.2. By Detection Range
      • 6.3.2.2.3. By Disease Are
      • 6.3.2.2.4. By End-Use Industry
  • 6.3.3. Mexico C-reactive Protein Testing Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Assay Type
      • 6.3.3.2.2. By Detection Range
      • 6.3.3.2.3. By Disease Are
      • 6.3.3.2.4. By End-Use Industry

7. Europe C-reactive Protein Testing Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Assay Type
  • 7.2.2. By Detection Range
  • 7.2.3. By Disease Are
  • 7.2.4. By End-Use Industry
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany C-reactive Protein Testing Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Assay Type
      • 7.3.1.2.2. By Detection Range
      • 7.3.1.2.3. By Disease Are
      • 7.3.1.2.4. By End-Use Industry
  • 7.3.2. United Kingdom C-reactive Protein Testing Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Assay Type
      • 7.3.2.2.2. By Detection Range
      • 7.3.2.2.3. By Disease Are
      • 7.3.2.2.4. By End-Use Industry
  • 7.3.3. Italy C-reactive Protein Testing Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Assay Type
      • 7.3.3.2.2. By Detection Range
      • 7.3.3.2.3. By Disease Are
      • 7.3.3.2.4. By End-Use Industry
  • 7.3.4. France C-reactive Protein Testing Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Assay Type
      • 7.3.4.2.2. By Detection Range
      • 7.3.4.2.3. By Disease Are
      • 7.3.4.2.4. By End-Use Industry
  • 7.3.5. Spain C-reactive Protein Testing Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Assay Type
      • 7.3.5.2.2. By Detection Range
      • 7.3.5.2.3. By Disease Are
      • 7.3.5.2.4. By End-Use Industry

8. Asia-Pacific C-reactive Protein Testing Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Assay Type
  • 8.2.2. By Detection Range
  • 8.2.3. By Disease Are
  • 8.2.4. By End-Use Industry
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China C-reactive Protein Testing Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Assay Type
      • 8.3.1.2.2. By Detection Range
      • 8.3.1.2.3. By Disease Are
      • 8.3.1.2.4. By End-Use Industry
  • 8.3.2. India C-reactive Protein Testing Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Assay Type
      • 8.3.2.2.2. By Detection Range
      • 8.3.2.2.3. By Disease Are
      • 8.3.2.2.4. By End-Use Industry
  • 8.3.3. Japan C-reactive Protein Testing Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Assay Type
      • 8.3.3.2.2. By Detection Range
      • 8.3.3.2.3. By Disease Are
      • 8.3.3.2.4. By End-Use Industry
  • 8.3.4. South Korea C-reactive Protein Testing Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Assay Type
      • 8.3.4.2.2. By Detection Range
      • 8.3.4.2.3. By Disease Are
      • 8.3.4.2.4. By End-Use Industry
  • 8.3.5. Australia C-reactive Protein Testing Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Assay Type
      • 8.3.5.2.2. By Detection Range
      • 8.3.5.2.3. By Disease Are
      • 8.3.5.2.4. By End-Use Industry

9. South America C-reactive Protein Testing Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Assay Type
  • 9.2.2. By Detection Range
  • 9.2.3. By Disease Are
  • 9.2.4. By End-Use Industry
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil C-reactive Protein Testing Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Assay Type
      • 9.3.1.2.2. By Detection Range
      • 9.3.1.2.3. By Disease Are
      • 9.3.1.2.4. By End-Use Industry
  • 9.3.2. Argentina C-reactive Protein Testing Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Assay Type
      • 9.3.2.2.2. By Detection Range
      • 9.3.2.2.3. By Disease Are
      • 9.3.2.2.4. By End-Use Industry
  • 9.3.3. Colombia C-reactive Protein Testing Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Assay Type
      • 9.3.3.2.2. By Detection Range
      • 9.3.3.2.3. By Disease Are
      • 9.3.3.2.4. By End-Use Industry

10. Middle East and Africa C-reactive Protein Testing Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Assay Type
  • 10.2.2. By Detection Range
  • 10.2.3. By Disease Are
  • 10.2.4. By End-Use Industry
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa C-reactive Protein Testing Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Assay Type
      • 10.3.1.2.2. By Detection Range
      • 10.3.1.2.3. By Disease Are
      • 10.3.1.2.4. By End-Use Industry
  • 10.3.2. Saudi Arabia C-reactive Protein Testing Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Assay Type
      • 10.3.2.2.2. By Detection Range
      • 10.3.2.2.3. By Disease Are
      • 10.3.2.2.4. By End-Use Industry
  • 10.3.3. UAE C-reactive Protein Testing Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Assay Type
      • 10.3.3.2.2. By Detection Range
      • 10.3.3.2.3. By Disease Are
      • 10.3.3.2.4. By End-Use Industry

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global C-reactive Protein Testing Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Thermo Fisher Scientific, Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. F. Hoffmann-La Roche Ltd.
• 14.3. Danaher Corp
• 14.4. Quest Diagnostics
• 14.5. Siemens Healthineers AG
• 14.6. Abbott Laboratories Inc.
• 14.7. Merck KGaAA
• 14.8. Zoetis Inc.
• 14.9. Ortho Clinical Diagnostics
• 14.10.Getein Biotech, Inc.

15. Strategic Recommendations

16. About Us & Disclaimer